Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability.

Morton MF, Barrett TD, Freedman J, Li L, Rizzolio MC, Prendergast CE, Wu X, Moreno V, Pyati J, Figueroa K, Cagnon L, Lagaud G, Ver Donck L, Ghoos E, Allison B, Rabinowitz MH, Shankley NP.

J Pharmacol Exp Ther. 2011 Jul;338(1):328-36. doi: 10.1124/jpet.110.178483. Epub 2011 Apr 14.

PMID:
21493750
2.

Functional Characterization of the Canine Heme-Regulated eIF2alpha Kinase: Regulation of Protein Synthesis.

Kanelakis KC, Pyati J, Wagaman PC, Chuang JC, Yang Y, Shankley NP.

Adv Hematol. 2009;2009:251915. doi: 10.1155/2009/251915. Epub 2009 Jun 22.

3.

3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.

Morton MF, Barrett TD, Yan W, Freedman JM, Lagaud G, Prendergast CE, Moreno V, Pyati J, Figueroa K, Li L, Wu X, Rizzolio M, Breitenbucher JG, McClure K, Shankley NP.

J Pharmacol Exp Ther. 2007 Nov;323(2):562-9. Epub 2007 Aug 7.

PMID:
17684117
4.

Pharmacological analysis of CCK2 receptors up-regulated using engineered transcription factors.

Morton MF, Liu PQ, Reik A, de la Rosa R, Mendel M, Li XY, Case C, Pabo C, Moreno V, Pyati J, Shankley NP.

Regul Pept. 2005 Jul 15;129(1-3):227-32.

PMID:
15927720
5.

Molecular cloning, expression and pharmacological characterization of the canine cholecystokinin 1 receptor.

Morton MF, Pyati J, Dai H, Li L, Moreno V, Shankley NP.

Br J Pharmacol. 2005 Jun;145(3):374-84.

6.

Cell lines for drug discovery: elevating target-protein levels using engineered transcription factors.

Liu PQ, Morton MF, Reik A, de la Rosa R, Mendel MC, Li XY, Case CC, Pabo CO, Moreno V, Kempf A, Pyati J, Shankley NP.

J Biomol Screen. 2004 Feb;9(1):44-51.

PMID:
15006148
7.

Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow.

Liu C, Ma X, Jiang X, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, Lovenberg TW.

Mol Pharmacol. 2001 Mar;59(3):420-6.

PMID:
11179434
8.

Cloning of rat histamine H(3) receptor reveals distinct species pharmacological profiles.

Lovenberg TW, Pyati J, Chang H, Wilson SJ, Erlander MG.

J Pharmacol Exp Ther. 2000 Jun;293(3):771-8.

PMID:
10869375
9.

Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery.

Roland BL, Sutton SW, Wilson SJ, Luo L, Pyati J, Huvar R, Erlander MG, Lovenberg TW.

Endocrinology. 1999 Dec;140(12):5736-45.

PMID:
10579339
10.

The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit.

Dubin AE, Huvar R, D'Andrea MR, Pyati J, Zhu JY, Joy KC, Wilson SJ, Galindo JE, Glass CA, Luo L, Jackson MR, Lovenberg TW, Erlander MG.

J Biol Chem. 1999 Oct 22;274(43):30799-810.

11.

Cloning and functional expression of the human histamine H3 receptor.

Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG.

Mol Pharmacol. 1999 Jun;55(6):1101-7.

PMID:
10347254
12.

Screening differentially expressed cDNA clones obtained by differential display using amplified RNA.

Poirier GM, Pyati J, Wan JS, Erlander MG.

Nucleic Acids Res. 1997 Feb 15;25(4):913-4.

13.

Cloning differentially expressed mRNAs.

Wan JS, Sharp SJ, Poirier GM, Wagaman PC, Chambers J, Pyati J, Hom YL, Galindo JE, Huvar A, Peterson PA, Jackson MR, Erlander MG.

Nat Biotechnol. 1996 Dec;14(13):1685-91.

PMID:
9634852
15.
16.

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.

Burton DR, Pyati J, Koduri R, Sharp SJ, Thornton GB, Parren PW, Sawyer LS, Hendry RM, Dunlop N, Nara PL, et al.

Science. 1994 Nov 11;266(5187):1024-7.

PMID:
7973652
17.

A revised strategy for cloning antibody gene fragments in bacteria.

Posner B, Lee I, Itoh T, Pyati J, Graff R, Thorton GB, La Polla R, Benkovic SJ.

Gene. 1993 Jun 15;128(1):111-7.

PMID:
8508951
18.

The serine protease cofactor factor V is synthesized by lymphocytes.

Shen NL, Fan ST, Pyati J, Graff R, LaPolla RJ, Edgington TS.

J Immunol. 1993 Apr 1;150(7):2992-3001.

PMID:
8454869
19.

Human combinatorial antibody libraries to hepatitis B surface antigen.

Zebedee SL, Barbas CF 3rd, Hom YL, Caothien RH, Graff R, DeGraw J, Pyati J, LaPolla R, Burton DR, Lerner RA, et al.

Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3175-9.

20.

Sequence and structural analysis of surface protein antigen I/II (SpaA) of Streptococcus sobrinus.

LaPolla RJ, Haron JA, Kelly CG, Taylor WR, Bohart C, Hendricks M, Pyati JP, Graff RT, Ma JK, Lehner T.

Infect Immun. 1991 Aug;59(8):2677-85.

21.

Bone marrow transplantation in Lesch-Nyhan disease.

Nyhan WL, Parkman R, Page T, Gruber HE, Pyati J, Jolly D, Friedmann T.

Adv Exp Med Biol. 1986;195 Pt A:167-70. No abstract available.

PMID:
3524132
22.

Activation of human beta-globin genes from nonerythroid cells by fusion with murine erythroleukemia cells.

Pyati J, Kucherlapati RS, Skoultchi AI.

Proc Natl Acad Sci U S A. 1980 Jun;77(6):3435-9.

23.
24.

Supplemental Content

Support Center